The American Chemical Society Committee on Meetings and Expositions (M&E) is responsible for the meetings function of ACS. This committee works closely with the ACS Department of Meetings and Expositions Services to ensure that ACS is a successful convener for the chemistry enterprise, where individuals can share science and network. The vision of M&E is "meetings that advance the global chemistry enterprise." Toward that end, the committee's mission is to "provide premiere meeting venues and platforms to amplify interdisciplinary chemical sciences and networking that are accessible and inclusive for all." One primary focus for M&E is the ACS Future of Meetings (FoM) initiative. ACS has been actively working to reimagine ACS meetings and how they need to evolve through the year 2030. Last year, the FoM initiative began as a collaboration between M&E, the Divisional Activities Committee, program chairs, ACS staff, and other stakeholders. The working group has also grown
No takes yet. Share an insight, caveat, or question.
Chair Amber S. Hinkle (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: